RT Journal Article SR Electronic T1 Maspin/SerpinB5 is a cytoskeleton-binding protein that regulates epithelial cell shape JF bioRxiv FD Cold Spring Harbor Laboratory SP 2024.09.09.612024 DO 10.1101/2024.09.09.612024 A1 da Silva, Luiz E. A1 Paim, Lia M.G. A1 Menezes, Ana P. J. A1 da Cunha, Julia P. C. A1 Bechstedt, Susanne A1 Cella, Nathalie YR 2024 UL http://biorxiv.org/content/early/2024/09/09/2024.09.09.612024.abstract AB Maspin/SerpinB5 is an abundant and pleiotropic protein mostly expressed by epithelia. Initially described as a tumor suppressor, it has been reported as a regulator of cell adhesion, migration, and invasion. How intracellular Maspin orchestrates these processes is poorly understood. In this study, we utilized Affinity purification-Mass spectrometry (AP/MS) alongside in vitro reconstitution assays to establish that Maspin directly interacts with microtubules and microfilaments. Additionally, CRISPR/Cas9-mediated GFP tagging of endogenous Maspin, combined with immunostaining, revealed its localization at the cortical cytoskeleton and the mitotic spindle. Depletion of Maspin by RNAi and CRISPR/Cas9 in three distinct epithelial cell lines disrupts cell-cell adhesion, reorganizes the cytoskeleton and results in upregulation of mesenchymal markers during interphase. In mitotic cells, loss of Maspin induces abnormal cell rounding and rearrangement of cortical F-actin. Moreover, Maspin suppresses microtubule growth in vitro and in cells. Collectively, these results demonstrate that Maspin acts at the interface between the cytoskeleton and adhesion sites, directly modulating cell shape and preventing epithelial-mesenchymal transition.Summary Da Silva et al. report that the non-inhibitory serpin Maspin (SerpinB5), which has long been implicated in the regulation of cell adhesion, migration, invasion and metastasis, directly binds to microfilaments and microtubules in vitro and in cells, acting at the interface between the cytoskeleton and adhesion sites.Competing Interest StatementThe authors have declared no competing interest.